DANIEL L KISNER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL L KISNER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL L KISNER. DANIEL L KISNER is Director in SEQUENOM INC ($SQNM) and Director in DYNAVAX TECHNOLOGIES CORP ($DVAX) and Director in Oncternal Therapeutics, Inc. ($GTXI) and Director in LPATH, INC ($LPTN) and Director in Conatus Pharmaceuticals Inc. ($CNAT) and Director in Zynerba Pharmaceuticals, Inc. ($ZYNE).
Latest Insider Trading Transactions of DANIEL L KISNER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LPTN, DVAX, HSTO, ONCT, SQNM, ZYNE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 09 2020 | CNAT | Histogen Inc. | KISNER DANIEL L | Director | Option Exercise | A | 1.89 | 20,000 | 37,800 | 20,000 | |
| Jul 23 2020 | ONCT | Oncternal Therapeu ... | KISNER DANIEL L | Director | Option Exercise | A | 2.32 | 5,000 | 11,600 | 5,000 | |
| Jul 23 2020 | ONCT | Oncternal Therapeu ... | KISNER DANIEL L | Director | Buy | P | 2.38 | 10,000 | 23,825 | 10,000 | 0 to 10 K |
| Jun 12 2020 | ONCT | Oncternal Therapeu ... | KISNER DANIEL L | Director | Option Exercise | A | 2.94 | 15,000 | 44,100 | 15,000 | |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| May 29 2020 | DVAX | DYNAVAX TECHNOLOGI ... | KISNER DANIEL L | Director | Option Exercise | A | 4.84 | 25,000 | 121,000 | 25,000 | |
| Sep 16 2019 | GTXI | Oncternal Therapeu ... | KISNER DANIEL L | Director | Option Exercise | A | 5.76 | 30,000 | 172,800 | 30,000 | |
| Jul 01 2019 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 0.29 | 20,000 | 5,800 | 20,000 | |
| Jun 13 2019 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 13.50 | 15,000 | 202,500 | 15,000 | |
| May 31 2019 | DVAX | DYNAVAX TECHNOLOGI ... | KISNER DANIEL L | Director | Option Exercise | A | 4.97 | 15,000 | 74,550 | 15,000 | |
| Jun 25 2018 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 4.99 | 20,000 | 99,800 | 20,000 | |
| Jun 07 2018 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 11.30 | 15,000 | 169,500 | 15,000 | |
| Jun 01 2018 | DVAX | DYNAVAX TECHNOLOGI ... | KISNER DANIEL L | Director | Option Exercise | A | 15.80 | 15,000 | 237,000 | 15,000 | |
| Jun 26 2017 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 4.96 | 20,000 | 99,200 | 20,000 | |
| Jun 09 2017 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 18.77 | 15,000 | 281,550 | 15,000 | |
| Jun 02 2017 | DVAX | DYNAVAX TECHNOLOGI ... | KISNER DANIEL L | Director | Option Exercise | A | 5.90 | 7,500 | 44,250 | 7,500 | |
| Dec 30 2016 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Buy | J | 0.00 | 2,310 | 0 | 5,455 | 3.1 K to 5.5 K (+73.45 %) |
| Jul 20 2016 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 7.90 | 15,000 | 118,500 | 15,000 | |
| Jun 24 2016 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 2.13 | 20,000 | 42,600 | 20,000 | |
| May 31 2016 | DVAX | DYNAVAX TECHNOLOGI ... | KISNER DANIEL L | Director | Option Exercise | A | 16.59 | 7,500 | 124,425 | 7,500 | |
| Feb 18 2016 | LPTN | LPATH, INC | KISNER DANIEL L | Director | Option Exercise | A | 0.16 | 25,000 | 3,888 | 25,000 | |
| Oct 14 2015 | DVAX | DYNAVAX TECHNOLOGI ... | KISNER DANIEL L | Director | Option Exercise | A | 22.51 | 13,200 | 297,132 | 13,200 | |
| Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 14.00 | 35,000 | 490,000 | 35,000 | |
| Jun 15 2015 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 5.52 | 15,000 | 82,800 | 15,000 | |
| May 28 2015 | DVAX | DYNAVAX TECHNOLOGI ... | KISNER DANIEL L | Director | Option Exercise | A | 22.36 | 7,500 | 167,700 | 7,500 | |
| Apr 10 2015 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Buy | P | 5.75 | 4,000 | 23,000 | 7,145 | 3.1 K to 7.1 K (+127.19 %) |
| May 18 2004 | SQNM | SEQUENOM INC | KISNER DANIEL L | Director | Option Exercise | A | 1.74 | 15,000 | 26,100 | 15,000 |
Page: 1